Document Detail

Systemic progesterone therapy-Oral, vaginal, injections and even transdermal?
MedLine Citation:
PMID:  25113944     Owner:  NLM     Status:  Publisher    
Several medicinal products containing progesterone are in widespread use orally for protection of the endometrium during concurrent oestrogen treatment, and injections or vaginally for support of luteal function during assisted reproduction. These indications have been established in extensive clinical testing programmes. In addition, the results of recent studies and meta-analyses suggest that vaginal progesterone is an effective method for preventing premature births in singleton pregnancies in women with a shortened cervix. In US, 17α-hydroxyprogesterone caproate is licensed to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. There is insufficient evidence from scientific studies to substantiate the transdermal application of progesterone. In particular, these preparations should not be used to oppose the effects of oestrogen on the endometrium, because even with low doses of estradiol a reliable progestogenic effect to protect the endometrium has not been proved. On the other hand, the application of transdermal progesterone preparations alone is not known to pose any risks to health.
Xiangyan Ruan; Alfred O Mueck
Related Documents :
16380564 - Breastfeeding duration and perinatal cigarette smoking in a population-based cohort.
16950984 - Effect of maternal smoking during pregnancy on offspring's cognitive ability: empirical...
7460764 - Changing patterns of soft drug use prior to and during pregnancy: a prospective study.
15152644 - Meaning constructs as predictors of bereavement adjustment: a report from the scott & w...
6180424 - Four years' experience of maternal alpha-fetoprotein screening and its effect on the pa...
11883354 - Intramuscular methotrexate for tubal pregnancy.
Publication Detail:
Type:  REVIEW     Date:  2014-7-22
Journal Detail:
Title:  Maturitas     Volume:  -     ISSN:  1873-4111     ISO Abbreviation:  Maturitas     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-8-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7807333     Medline TA:  Maturitas     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Static and rotational intensity modulated techniques for head-neck cancer radiotherapy: A planning c...
Next Document:  Recently targeted kinases and their inhibitors-the path to clinical trials.